Member Info for Troutisout1

Yeah because investors in a placing are going to sell the shares as soon are they are issued at a 10% discount to the price they bought at? LOL!

You still haven't pointed out where this happened last year when they had a similar placing at a much bigger discount and were in deep trouble and yet you think it will happen now when the discount was minimal, the prospects are much more positive and the Biotech/Pharm sector is seeing a resurgence. The Instis buying the placing will hold as they did last time.

Zac Mir's latest - Comment: It could be argued that fundamentally FAB is now on track as a recovery situation, with the purchase order and recent funding. Only a rise in the share price is missing."

I know they have to do a voting rights RNS every now and then, but seems pointless when that number is going to change next week?

And Micho will be over at AVCT telling them about their placing and what it all means....

She was the one asking for the views from genuine investors, well if she stopped listening to other people's views, especially the 'genuine investors' then she may have had to take her head out of the sand and formed her own view and saved some of her losses.

Unfortunately she has listened to too many scammers here and probably aided them getting out with a profit at her and others' expense.

Yet she still asks.......

It seems the dim one is the person that lost a packet, that they couldn't afford, investing in this before last years troubles, that then comes back to haunt the BBs in a fit of pique and has the temerity to call out other investors as dim....

We'll see what happens but from the last placing, it looks like several Institutions took up a lot of the placing and Directors the subscription, these all still hold those shares.

The retail offer only saw a 22% take up and yet these would have been the people able to make a quick turn if they so desired and they could have profited, so why didn't the SP sink back to the placing price immediately after the issue of shares? It took quite a while and more bad news before the SP sank back to the 5p level.

So I would think the same and more will happen here as the discount to the SP was extremely small and that is not likely to interest the bucket shops that you would like everyone to believe will be selling out on a sniff of a miniscule profit. I also see the news flow now turning positive and the SP reacting to that, as the turnaround continues to grow.

I've made my play and you obviously are unable to , so we will see if my opportunity or your bile, win the day....

Just the same traders trying to rinse a few again....

You seem to talk rubbish, why would anyone buy in a placing to then sell it again at what they bought at? Or even a small percentage higher than that, let alone below the price they paid in the placing.

This is just a chance for the market to shake out any week hands before the GM next week.

2 of them are from one person.

What's your view Sianna?

You like disagreeing....

What was a delayed sell?

DNP,

I think that is not quite right, the buyers yesterday did not know about it and the price rose as the buying outweighed the selling substantially.

There was no evidence of a seller yesterday (there was on Thursday and Friday) and the selling today seemed a little weird as they could have got better yesterday afternoon.

We will see what happens but I suspect the placing shares to be going to tight holdings and the newsflow to continue...

"Only a rise in the share price is missing."

It won't remain missing for too much longer....

Fusion Antibodies (FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announced it has received a first purchase order under the master services agreement (MSA) with a leading diagnostics company details of which were announced on 14 February 2024. FAB said reaching this agreement with a world class diagnostics provider positively reinforces the value to the wider commercial world of Fusion Antibodies’ technologies and capabilities. In this case it is the generation of antibodies in diagnostics products.

Comment: It could be argued that fundamentally FAB is now on track as a recovery situation, with the purchase order and recent funding. Only a rise in the share price is missing.

I got 3.885p, 3.84p, 3.896p and 3.9p on a fill or kill before the offer went up...All good prices and bringing my average down a little.

Will wait patiently now as I think this year will bring lots of positives (and maybe some perceived negatives).

I have added several times today (and I thought I had enough?), main one is delayed, traded at 09.11hrs...

I just think sub 3.9p is worth accumulating at...There has been a really positive shift in Biotech/Pharma in the last few months and CRO's are going to do well with the spending plans these Companies have to development new treatments, tests and trials.

Still maintain you don't know what you are talking about, the RNS clearly states Peel Hunt notified the Issuer on the 15th February (the day after they traded the shares).

It has been DKE who have delayed reporting it to the market this time......

I would suggest Peel Hunt only have to report when they go over 10% and that now they have gone under that, they have probably sold out entirely. This from another BB back at the time,

"tomboyb 16 Feb '24 - 10:45 - 360 of 360

0 0 0

I have to wonder though 30mill traded yesterday -

Peel fully offloaded? -"

The last two trades were UT trades from the auctions so not the MMs spread. Basically if someone wants to sell at 0.27p and the offer at that price in the auction, someone is likely to take them up and it trades there.

The spread is wide, but the MMs aren't sure where it is going to go and with lack of volume are going to all sit together on the same wide spread.

Give it some newsflow and the spread will tighten.

So looking at the last placing, which was at a massive discount the shares seemed to have been taken by IIs and they still seem to be holding them , so if we see the same investors for this funding round, we could have quite a set of 'safe hands' investors on board and therefore the SP trajectory would have less drag on it. Even looking at last year, the SP didn't really get affected with the post placing trading, more about the problems the business was facing. Hopefully now they are cashed up and see the visibility to increased revenues and will be working towards the breakeven level in their numbers....

I'm glad it did though :o)